Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_445
Snippet: There were significant changes in maximum amplitude (P = 0.04) and G values (P = 0.04), suggesting that HSS affects whole blood coagulation differently, according to the study design. Unlike in previous in vitro studies, which revealed that 7.5% HSS has anticoagulant effects, a clinically relevant dose (5 mL/kg) of 7.5% HSS had no effect on whole blood coagulation when compared with 0.9% normal saline in vivo. The purpose of this study is to eval.....
Document: There were significant changes in maximum amplitude (P = 0.04) and G values (P = 0.04), suggesting that HSS affects whole blood coagulation differently, according to the study design. Unlike in previous in vitro studies, which revealed that 7.5% HSS has anticoagulant effects, a clinically relevant dose (5 mL/kg) of 7.5% HSS had no effect on whole blood coagulation when compared with 0.9% normal saline in vivo. The purpose of this study is to evaluate the ability of two human complement inhibitors to inhibit canine complementmediated hemolyisis in vitro and to validate the use of an ELISA for detection of canine complement activation in dogs.
Search related documents:
Co phrase search for related documents- anticoagulant effect and study purpose: 1
- anticoagulant effect and vitro study: 1
- blood coagulation and complement activation: 1, 2, 3, 4, 5, 6, 7, 8, 9
- blood coagulation and maximum amplitude: 1
- blood coagulation and normal saline: 1
- blood coagulation and significant change: 1, 2, 3, 4
- blood coagulation and study design: 1, 2, 3
- blood coagulation and study purpose: 1, 2, 3, 4, 5
- blood coagulation and vitro study: 1
- canine complement activation and complement activation: 1
Co phrase search for related documents, hyperlinks ordered by date